TW526268B - Method for producing a fermented milk product - Google Patents
Method for producing a fermented milk product Download PDFInfo
- Publication number
- TW526268B TW526268B TW087115782A TW87115782A TW526268B TW 526268 B TW526268 B TW 526268B TW 087115782 A TW087115782 A TW 087115782A TW 87115782 A TW87115782 A TW 87115782A TW 526268 B TW526268 B TW 526268B
- Authority
- TW
- Taiwan
- Prior art keywords
- lactic acid
- milk
- fermented
- acid bacteria
- strain
- Prior art date
Links
- 235000014048 cultured milk product Nutrition 0.000 title claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 title claims description 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 138
- 239000004310 lactic acid Substances 0.000 claims abstract description 61
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 61
- 241000894006 Bacteria Species 0.000 claims abstract description 58
- 235000013336 milk Nutrition 0.000 claims abstract description 52
- 239000008267 milk Substances 0.000 claims abstract description 52
- 210000004080 milk Anatomy 0.000 claims abstract description 52
- 230000000694 effects Effects 0.000 claims abstract description 27
- 240000002605 Lactobacillus helveticus Species 0.000 claims abstract description 19
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims abstract description 18
- 235000013305 food Nutrition 0.000 claims abstract description 18
- 229940054346 lactobacillus helveticus Drugs 0.000 claims abstract description 18
- 239000007787 solid Substances 0.000 claims abstract description 15
- 235000013861 fat-free Nutrition 0.000 claims abstract description 14
- 235000020244 animal milk Nutrition 0.000 claims abstract description 13
- 235000015140 cultured milk Nutrition 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 23
- 238000000855 fermentation Methods 0.000 claims description 21
- 230000004151 fermentation Effects 0.000 claims description 21
- 239000012634 fragment Substances 0.000 claims description 20
- 235000021001 fermented dairy product Nutrition 0.000 claims description 16
- 238000011049 filling Methods 0.000 claims description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 15
- 210000004027 cell Anatomy 0.000 claims description 14
- 235000000346 sugar Nutrition 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 101710089384 Extracellular protease Proteins 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 235000018102 proteins Nutrition 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 108010073771 Soybean Proteins Proteins 0.000 claims description 5
- 241000209140 Triticum Species 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 4
- 239000005018 casein Substances 0.000 claims description 4
- 235000013351 cheese Nutrition 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 235000013618 yogurt Nutrition 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- 235000013402 health food Nutrition 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 230000004899 motility Effects 0.000 claims description 3
- 108091008146 restriction endonucleases Proteins 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- 241000157282 Aesculus Species 0.000 claims description 2
- 102000016938 Catalase Human genes 0.000 claims description 2
- 108010053835 Catalase Proteins 0.000 claims description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 229910002651 NO3 Inorganic materials 0.000 claims description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 230000009603 aerobic growth Effects 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 2
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 230000002079 cooperative effect Effects 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 235000010181 horse chestnut Nutrition 0.000 claims description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 230000000877 morphologic effect Effects 0.000 claims description 2
- 230000001766 physiological effect Effects 0.000 claims description 2
- 235000021067 refined food Nutrition 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000019710 soybean protein Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 210000003578 bacterial chromosome Anatomy 0.000 claims 1
- 235000013409 condiments Nutrition 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 7
- 108091005804 Peptidases Proteins 0.000 abstract description 4
- 230000002180 anti-stress Effects 0.000 abstract description 4
- 102000035195 Peptidases Human genes 0.000 abstract description 2
- 235000019833 protease Nutrition 0.000 abstract description 2
- DOFAQXCYFQKSHT-SRVKXCTJSA-N Val-Pro-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DOFAQXCYFQKSHT-SRVKXCTJSA-N 0.000 abstract 2
- 108010015385 valyl-prolyl-proline Proteins 0.000 abstract 2
- FQYQMFCIJNWDQZ-CYDGBPFRSA-N Ile-Pro-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 FQYQMFCIJNWDQZ-CYDGBPFRSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000721 bacterilogical effect Effects 0.000 abstract 1
- 235000013361 beverage Nutrition 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 description 16
- 239000001963 growth medium Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 235000020183 skimmed milk Nutrition 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- JREYOWJEWZVAOR-UHFFFAOYSA-N triazanium;[3-methylbut-3-enoxy(oxido)phosphoryl] phosphate Chemical compound [NH4+].[NH4+].[NH4+].CC(=C)CCOP([O-])(=O)OP([O-])([O-])=O JREYOWJEWZVAOR-UHFFFAOYSA-N 0.000 description 8
- 235000013365 dairy product Nutrition 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000013611 chromosomal DNA Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 108050001049 Extracellular proteins Proteins 0.000 description 4
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 3
- 235000017491 Bambusa tulda Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 244000082204 Phyllostachys viridis Species 0.000 description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000011425 bamboo Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 235000015067 sauces Nutrition 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000020251 goat milk Nutrition 0.000 description 2
- 235000021552 granulated sugar Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000020252 horse milk Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- AAXWBCKQYLBQKY-IRXDYDNUSA-N (2s)-2-[[(2s)-2-[(2-benzamidoacetyl)amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-4-methylpentanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)C=1C=CC=CC=1)C1=CN=CN1 AAXWBCKQYLBQKY-IRXDYDNUSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 108010076804 DNA Restriction Enzymes Proteins 0.000 description 1
- 230000007064 DNA hydrolysis Effects 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- XYZZKVRWGOWVGO-UHFFFAOYSA-N Glycerol-phosphate Chemical compound OP(O)(O)=O.OCC(O)CO XYZZKVRWGOWVGO-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 101000720079 Stichodactyla helianthus DELTA-stichotoxin-She4a Proteins 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 235000020167 acidified milk Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 108010016268 hippuryl-histidyl-leucine Proteins 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000021262 sour milk Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 150000007968 uric acids Chemical class 0.000 description 1
- 239000008371 vanilla flavor Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/137—Thickening substances
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dairy Products (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9277949A JP3028411B2 (ja) | 1997-09-26 | 1997-09-26 | トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW526268B true TW526268B (en) | 2003-04-01 |
Family
ID=17590526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW087115782A TW526268B (en) | 1997-09-26 | 1998-09-22 | Method for producing a fermented milk product |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US6534304B1 (OSRAM) |
| EP (1) | EP1016709B1 (OSRAM) |
| JP (1) | JP3028411B2 (OSRAM) |
| KR (1) | KR100404154B1 (OSRAM) |
| CN (1) | CN1149279C (OSRAM) |
| AR (1) | AR017153A1 (OSRAM) |
| AT (1) | ATE294230T1 (OSRAM) |
| AU (1) | AU734422B2 (OSRAM) |
| BG (1) | BG64422B1 (OSRAM) |
| BR (1) | BR9813218A (OSRAM) |
| CA (1) | CA2304985C (OSRAM) |
| CZ (1) | CZ291067B6 (OSRAM) |
| DE (1) | DE69829983T2 (OSRAM) |
| ES (1) | ES2237834T3 (OSRAM) |
| HU (1) | HU225980B1 (OSRAM) |
| IN (1) | IN188418B (OSRAM) |
| MY (1) | MY118157A (OSRAM) |
| PL (1) | PL188675B1 (OSRAM) |
| PT (1) | PT1016709E (OSRAM) |
| SK (1) | SK284755B6 (OSRAM) |
| TR (1) | TR200000854T2 (OSRAM) |
| TW (1) | TW526268B (OSRAM) |
| WO (1) | WO1999016862A1 (OSRAM) |
| ZA (1) | ZA988659B (OSRAM) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI414305B (zh) * | 2007-03-27 | 2013-11-11 | Calpis Co Ltd | 腎衰竭預防劑 |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000041572A1 (fr) | 1999-01-11 | 2000-07-20 | Calpis Co., Ltd. | Procede de production de lait fermente renfermant un peptide inhibiteur de l'enzyme de conversion de l'angiotensine et procede de production de lactoserum |
| FR2793257B1 (fr) * | 1999-05-06 | 2001-07-27 | Gervais Danone Sa | Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations |
| FI113741B (fi) | 1999-11-01 | 2004-06-15 | Valio Oy | Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi |
| JP4633876B2 (ja) * | 1999-11-11 | 2011-02-16 | カルピス株式会社 | トリペプチドの製造方法 |
| FI112031B (fi) | 2002-02-25 | 2003-10-31 | Valio Oy | Biologisesti aktiivisen tuotteen uusi käyttö |
| WO2003082019A2 (en) * | 2002-04-03 | 2003-10-09 | Chr. Hansen A/S | Peptides with anti-hypertensive properties |
| EP1529114A1 (en) * | 2002-08-09 | 2005-05-11 | Chr. Hansen A/S | Process for preparing peptides with anti-hypertensive properties |
| CN1735347A (zh) | 2003-01-06 | 2006-02-15 | 荷兰联合利华有限公司 | 含有三肽vpp和/或ipp的发酵乳制品 |
| TWI344371B (en) * | 2003-03-18 | 2011-07-01 | Suntory Holdings Ltd | Angiotensin-converting enzyme inhibitory peptides |
| US7718171B2 (en) | 2003-04-07 | 2010-05-18 | Chr. Hansen A/S | Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus |
| AU2004237455B2 (en) * | 2003-05-05 | 2007-08-02 | Dsm Ip Assets B.V. | Hydrolysed casein product comprising tripeptides IPP and/ or VPP |
| JP4680571B2 (ja) * | 2003-12-25 | 2011-05-11 | カルピス株式会社 | 経口摂取用保湿剤 |
| US20070224285A1 (en) * | 2004-03-31 | 2007-09-27 | Calpis Co., Ltd | Agent for Preventing or Suppressing Hepatopathy and Functional Food for Preventing or Suppressing Hepatopathy |
| WO2005094849A1 (ja) * | 2004-03-31 | 2005-10-13 | Calpis Co., Ltd. | 内因性メラトニン分泌リズム改善用機能性食品、及び概日リズム改善用機能性食品 |
| JP4723501B2 (ja) * | 2004-07-05 | 2011-07-13 | カルピス株式会社 | ペプチド混合物の製造法、抗高血圧ペプチド含有発酵乳の製造法及び抗高血圧ペプチド製剤の製造法 |
| BRPI0514903A (pt) | 2004-09-03 | 2008-06-24 | Hansens Lab | proteìnas vegetais ou leite fermentado compreendendo ligando de receptor e uso dos mesmos |
| JPWO2006095764A1 (ja) * | 2005-03-09 | 2008-08-14 | カルピス株式会社 | 皮膚における紫外線感受性抑制剤及び機能性飲食品 |
| TW200740378A (en) * | 2005-06-24 | 2007-11-01 | Calpis Co Ltd | Epidermal differentiation and keratinization promoter and functional food and beverage for promoting epidermal keratinization |
| CN1903052B (zh) * | 2005-07-26 | 2010-04-28 | 天津科技大学 | 具有酪蛋白磷酸肽、抗血管紧张素转化酶肽和低聚半乳糖乳清粉的制备方法 |
| BRPI0613979A2 (pt) * | 2005-07-26 | 2011-02-22 | Calpis Co Ltd | processo para a produção de leite fermentado e bebida/alimento feito a partir de leite fermentado |
| CN101420969B (zh) * | 2006-02-14 | 2013-03-20 | 卡尔皮斯株式会社 | 动脉硬化预防剂、血管内膜增厚抑制剂以及血管内皮功能改善剂 |
| CN101420968B (zh) | 2006-02-14 | 2011-12-21 | 卡尔皮斯株式会社 | 血管扩张药 |
| ATE503388T1 (de) * | 2006-02-20 | 2011-04-15 | Gervais Danone Sa | Neue lactobacillus helveticus stämme |
| ES2384096T3 (es) * | 2006-02-20 | 2012-06-29 | Compagnie Gervais Danone | Cepas de Lactobacillus helveticus que no fermentan la lactosa |
| PT1820850E (pt) * | 2006-02-20 | 2009-05-29 | Gervais Danone Sa | Novas estirpes de lactobacillus helveticus |
| PT1820849E (pt) * | 2006-02-20 | 2009-04-24 | Gervais Danone Sa | Novas estirpes de lactobacillus helveticus |
| CN101443031A (zh) * | 2006-05-15 | 2009-05-27 | 瓦利奥有限公司 | 治疗用肽的新应用 |
| US20100034924A1 (en) | 2006-06-16 | 2010-02-11 | Christophe Fremaux | Bacterium |
| WO2008029505A1 (fr) | 2006-09-04 | 2008-03-13 | Snow Brand Milk Products Co., Ltd. | Agent d'accélération de l'accroissement et/ou la prévention de diminution dans le niveau d'adiponectine dans le sang, et inhibiteur de l'accumulation de graisse viscérale |
| JP2008214253A (ja) | 2007-03-02 | 2008-09-18 | Snow Brand Milk Prod Co Ltd | 内臓脂肪減少剤 |
| JP5292632B2 (ja) * | 2007-03-27 | 2013-09-18 | カルピス株式会社 | 心不全予防剤 |
| BRPI0915107A2 (pt) * | 2008-06-12 | 2015-08-11 | Nestec Sa | Cepas de lactobacillus heveticus para produção de peptídeos hipotensivos |
| EP2206439B1 (en) * | 2008-12-29 | 2012-04-18 | Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House | Frozen confectionery products comprising theobromine and caffeine |
| EP2531195A1 (en) * | 2010-02-04 | 2012-12-12 | Unilever NV | Use of theobromine for lowering central blood pressure |
| CA2798911C (en) | 2010-05-19 | 2018-07-03 | Unilever Plc | Theobromine for increasing hdl-cholesterol |
| JP2010183918A (ja) * | 2010-06-01 | 2010-08-26 | Calpis Co Ltd | トリペプチドの製造方法 |
| JP5797891B2 (ja) * | 2010-11-09 | 2015-10-21 | カルピス株式会社 | Ｎｏｎ−ｄｉｐｐｅｒ型血圧日内変動による疾病発症リスク軽減剤 |
| JP5888701B2 (ja) * | 2010-11-09 | 2016-03-22 | アサヒグループホールディングス株式会社 | 高タンパク質分解活性を有するラクトバチルス・ヘルベティカス菌 |
| RU2453593C1 (ru) * | 2011-04-21 | 2012-06-20 | Общество с ограниченной ответственностью "Бифилюкс" | Штамм lactobacillus helveticus, используемый для получения продукции, содержащей лактобактерии |
| US20120328735A1 (en) * | 2011-06-24 | 2012-12-27 | Naoto Uchida | Process for preparing casein-derived peptides by fermentation of lactic acid bacteria |
| DE102012016127A1 (de) | 2011-08-31 | 2013-02-28 | Daniel Elias | Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels |
| AU2013305725B2 (en) | 2012-08-22 | 2017-05-11 | Kraft Foods Group Brands Llc | Processed cheese with cultured dairy components and method of manufacturing |
| CN102960444A (zh) * | 2012-11-19 | 2013-03-13 | 陕西科技大学 | 一种基于瑞士乳杆菌发酵的含ace抑制肽的羊奶的制备方法 |
| CN104450574B (zh) * | 2014-12-10 | 2017-05-10 | 生合生物科技（南京）有限公司 | 一种瑞士乳杆菌lh43及其制作乳酸菌饮料的方法 |
| RU2577112C1 (ru) * | 2014-12-25 | 2016-03-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" | Штамм lactobacillus helveticus вкпм в-11175, полученный на доступных питательных средах |
| CN107674848A (zh) * | 2017-09-20 | 2018-02-09 | 云南乍甸乳业有限责任公司 | 一种酸奶发酵菌种的制备方法 |
| CN111227049B (zh) * | 2018-11-29 | 2022-08-12 | 内蒙古伊利实业集团股份有限公司 | 一种维持褐色植物基酸奶货架期内组织状态稳定性的方法 |
| CN109517763B (zh) * | 2018-12-27 | 2022-03-22 | 内蒙古农业大学 | 瑞士乳杆菌h11及其应用 |
| CN110226687A (zh) * | 2019-06-12 | 2019-09-13 | 宁波依萃健生物科技有限公司 | 一种解酒护肝组合物及制备方法 |
| EP3845069B1 (en) * | 2019-12-30 | 2022-08-24 | Compagnie Gervais Danone | Sucrose negative streptococcus thermophilus for use in preparation of fermented products |
| CN111979286B (zh) * | 2020-08-31 | 2021-11-26 | 鲁东大学 | 一种发酵法与酶法联合制备贝类高f值寡肽的方法 |
| CN112616925A (zh) * | 2020-12-30 | 2021-04-09 | 光明乳业股份有限公司 | 一种双蛋白发酵乳及其制备方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3846560A (en) * | 1971-07-22 | 1974-11-05 | Quaker Oats Co | Process of making a base for protein beverages |
| US3876806A (en) * | 1971-10-14 | 1975-04-08 | Quaker Oats Co | Process for the preparation of acid soluble polypeptides and carbonated beverages containing same |
| US4107334A (en) * | 1976-10-13 | 1978-08-15 | Pfizer Inc. | Modified protein |
| CH636248A5 (fr) * | 1979-03-09 | 1983-05-31 | Nestle Sa | Procede de preparation d'un hydrolysat de proteines purifie. |
| JPS60262561A (ja) * | 1984-06-08 | 1985-12-25 | House Food Ind Co Ltd | 大豆蛋白質水溶液の処理方法 |
| US4585757A (en) * | 1984-07-27 | 1986-04-29 | Texas Tech University Health Sciences Center | Hypotensive active peptides |
| US4687840A (en) * | 1986-02-11 | 1987-08-18 | Texas Tech University Health Sciences Center | Hypotensive active peptides |
| GB8823429D0 (en) * | 1988-10-05 | 1988-11-09 | Agricultural Genetics Co | Method for accelerated ripening of cheddar & related hard type cheese |
| DD300815A5 (de) * | 1989-07-07 | 1992-08-06 | Nestle Sa | Proteinhydrolyse |
| NL9000422A (nl) * | 1990-02-21 | 1991-09-16 | Nl Zuivelonderzoek Inst | Werkwijze voor de bereiding van een gefermenteerd melkprodukt. |
| EP0445606B1 (en) * | 1990-02-27 | 1997-01-22 | The Agency of Industrial Science and Technology | Novel oligopeptides, pharmaceutical composition and food containing the same, and use of oligopeptides |
| EP0457565B1 (en) * | 1990-05-18 | 1997-07-30 | Morinaga Milk Industry Co., Ltd. | Milk-protein hydrolyzates and compositions for use as hair and skin treating agent |
| JP2571734B2 (ja) * | 1991-08-23 | 1997-01-16 | 株式会社ヤクルト本社 | 乳酸菌飲料 |
| US5486461A (en) * | 1991-11-08 | 1996-01-23 | Novo Nordisk A/S | Casein hydrolyzate and method for production of such casein hydrolyzate |
| FI94088C (fi) * | 1992-03-13 | 1995-07-25 | Valio Oy | Menetelmä fenyylialaniinin poistamiseksi proteiinipitoisista koostumuksista |
| US5418218A (en) * | 1992-07-10 | 1995-05-23 | The University Of Maryland At Baltimore | Histidyl-proline diketopiperazine (cyclo his-pro) a cns-active pharmacologic agent |
| JP2782142B2 (ja) | 1992-07-23 | 1998-07-30 | カルピス株式会社 | アンジオテンシン変換酵素阻害剤及びその製造法 |
| JP2782153B2 (ja) | 1992-11-09 | 1998-07-30 | カルピス株式会社 | アンジオテンシン変換酵素阻害ペプチドの製造法 |
| US5656268A (en) * | 1995-04-21 | 1997-08-12 | Sorodsky; Michael | Biological product |
| US5618689A (en) * | 1995-05-25 | 1997-04-08 | Nestec S.A. | Enhanced procedures for preparing food hydrolysates |
| DE69712912T2 (de) * | 1996-12-23 | 2002-11-21 | Dsm N.V., Heerlen | Verfahren zur herstellung eines proteinhydrolysates |
| US6221423B1 (en) * | 1998-04-13 | 2001-04-24 | Protein Technologies Int'l Inc. | Short-chained peptide material |
| AU2001247334A1 (en) | 2000-03-10 | 2001-09-24 | Monsanto Company | Novel peptides with anti-hypertensive activity |
| WO2001068113A1 (en) | 2000-03-10 | 2001-09-20 | Monsanto Technology Llc | Anti-hypertensive peptides |
| NZ518375A (en) | 2000-03-13 | 2003-07-25 | Morinaga Milk Industry Co Ltd | Protein hydrolyzates, process for producing the same and drinks and foods containing the protein hydrolyzates |
| US20030040475A1 (en) | 2001-01-16 | 2003-02-27 | Yasuhiro Toba | Agents for improving lipid metabolism and reducing high blood pressure |
| US6815426B2 (en) | 2001-02-16 | 2004-11-09 | E. I. Du Pont De Nemours And Company | Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| WO2002071854A1 (en) | 2001-03-09 | 2002-09-19 | Unilever N.V. | Fermented milk product |
| US6589574B2 (en) | 2001-03-19 | 2003-07-08 | Council Of Scientific & Industrial Research | Process for preparation of protein-hydrolysate from milk protein |
-
1997
- 1997-09-26 JP JP9277949A patent/JP3028411B2/ja not_active Expired - Lifetime
-
1998
- 1998-02-05 PT PT98901520T patent/PT1016709E/pt unknown
- 1998-02-05 KR KR10-2000-7003224A patent/KR100404154B1/ko not_active Expired - Fee Related
- 1998-02-05 BR BR9813218-0A patent/BR9813218A/pt not_active Application Discontinuation
- 1998-02-05 CZ CZ20001082A patent/CZ291067B6/cs not_active IP Right Cessation
- 1998-02-05 HU HU0003744A patent/HU225980B1/hu not_active IP Right Cessation
- 1998-02-05 PL PL98339343A patent/PL188675B1/pl unknown
- 1998-02-05 CA CA002304985A patent/CA2304985C/en not_active Expired - Fee Related
- 1998-02-05 AT AT98901520T patent/ATE294230T1/de active
- 1998-02-05 TR TR2000/00854T patent/TR200000854T2/xx unknown
- 1998-02-05 ES ES98901520T patent/ES2237834T3/es not_active Expired - Lifetime
- 1998-02-05 DE DE69829983T patent/DE69829983T2/de not_active Expired - Lifetime
- 1998-02-05 SK SK435-2000A patent/SK284755B6/sk not_active IP Right Cessation
- 1998-02-05 US US09/508,840 patent/US6534304B1/en not_active Expired - Fee Related
- 1998-02-05 AU AU57802/98A patent/AU734422B2/en not_active Ceased
- 1998-02-05 WO PCT/JP1998/000481 patent/WO1999016862A1/ja active IP Right Grant
- 1998-02-05 EP EP98901520A patent/EP1016709B1/en not_active Expired - Lifetime
- 1998-02-05 CN CNB988115301A patent/CN1149279C/zh not_active Expired - Fee Related
- 1998-09-17 IN IN2795DE1998 patent/IN188418B/en unknown
- 1998-09-22 TW TW087115782A patent/TW526268B/zh not_active IP Right Cessation
- 1998-09-23 MY MYPI98004363A patent/MY118157A/en unknown
- 1998-09-25 ZA ZA988659A patent/ZA988659B/xx unknown
- 1998-09-25 AR ARP980104806A patent/AR017153A1/es active IP Right Grant
-
2000
- 2000-04-26 BG BG104382A patent/BG64422B1/bg unknown
-
2002
- 2002-12-05 US US10/310,628 patent/US7282354B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI414305B (zh) * | 2007-03-27 | 2013-11-11 | Calpis Co Ltd | 腎衰竭預防劑 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW526268B (en) | Method for producing a fermented milk product | |
| Fortina et al. | Lactobacillus helveticus heterogeneity in natural cheese starters: the diversity in phenotypic characteristics | |
| JP2002233391A (ja) | 高分子量のポリ−γ−グルタミン酸を生産する耐塩性バチルスズブチリスチョングッチャン株 | |
| JP2824821B2 (ja) | 乳酸菌及び発酵乳製品 | |
| TW201038735A (en) | Aspergillus having large-scale genomic duplication and its use | |
| CN102575245B (zh) | 具有增强的蛋白酶活性的酱油曲霉突变株及使用该突变株制备天然味道增强剂的方法 | |
| JP3910634B2 (ja) | Ｐｆ１０２２物質を産生する形質転換体、及び糸状菌綱に属する菌の形質転換方法 | |
| CN100451127C (zh) | 制备具有抗高血压特性的肽的方法 | |
| JP2018525988A (ja) | 血栓溶解酵素の高生産のバチルス・サブチリス菌株 | |
| Vasantha et al. | Optimization of cultural conditions for the production of an extracellular protease by Pseudomonas species | |
| Agyei et al. | Carbohydrate utilization affects Lactobacillus delbrueckii subsp. lactis 313 cell-enveloped-associated proteinase production | |
| JP3618122B2 (ja) | 新規なラクトバチルス属菌株、たんぱく質及びそのシークエンスならびにこれらの菌株、たんぱく質及びシークエンスの利用法 | |
| CN1054350A (zh) | 发酵食品产品的生产 | |
| Simova et al. | Effect of growth phase and growth medium on peptidase activities of starter lactic acid bacteria | |
| JP4135846B2 (ja) | アミノ酸脱炭酸作用を有しない乳酸菌の取得方法 | |
| Montazeri et al. | Isolation, identification, and characterization of lactic acidic bacteria isolated from the raw milk of a single-humped camel | |
| Ritt et al. | Peptidases specific for proline‐containing peptides and their unusual peptide‐dependent regulation in Oenococcus oeni | |
| CN117070394B (zh) | 产碱性蛋白酶的嗜碱性菌株、碱性蛋白酶及其应用 | |
| KR100222419B1 (ko) | Ace 저해 펩타이드를 생산하는 락토바실러스 카제이 hy418 | |
| EP3345993A1 (en) | New strain isolated from traditional meju, soybean koji preparation method using same, and soybean koji prepared by same preparation method | |
| TWI227273B (en) | DNA molecule encoding transglutaminase, transglutaminase, expression vector containing the sequence and cell containing the expression vector | |
| JP3516318B2 (ja) | 新規エンドペプチダーゼ | |
| KR20010090321A (ko) | 브레비바실러스 보스테렌시스 ｂｃｓ-1 에서 유래한 신규내열성 ｄ-입체특이적 디펩티다아제 및 이를 이용한ｄ-아미노산 함유 펩타이드의 합성 방법 | |
| Grozeva et al. | Effect of crude extract of Lactobacillus in increasing the amino N and acetaldehyde levels in yogurt | |
| JPH0530968A (ja) | 新規プロリンジペプチダーゼおよびその製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GD4A | Issue of patent certificate for granted invention patent | ||
| MK4A | Expiration of patent term of an invention patent |